Distinguished in Lung Cancer

Dr. Daniel Sterman

Intensive Care Medicine
NYU Langone Internal Medicine Associates
222 E 41st St, 
New York, NY 
Offers Telehealth
Distinguished in Lung Cancer
NYU Langone Internal Medicine Associates
222 E 41st St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Sterman is an Intensive Care Medicine provider in New York, New York. Dr. Sterman is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Pleural Effusion, Lung Nodules, Endoscopy, and Advanced Bronchoscopy.

His clinical research consists of co-authoring 98 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 48 articles and participated in 4 clinical trials in the study of Lung Cancer.

Specialties
Intensive Care Medicine
Licenses
Critical Care Medicine in PA
Hospital Affiliations
Nyu Langone Hospitals
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
HealthPartners
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

NYU Langone Internal Medicine Associates
222 E 41st St, New York, NY 10017
Call: 212-263-8865
Other Locations
NYU Langone Cardiology Associates
530 1st Ave Ste 5D, New York, NY 10016
Call: 212-263-7951

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC Patients
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC Patients
Enrollment Status: Active_not_recruiting
Publish Date: August 22, 2025
Intervention Type: Biological
Study Drug: Aglatimagene besadenovec
Study Phase: Phase 2
Single-Arm, Phase II of Immunotherapy With Pembrolizumab for the Prevention of Lung Cancer (IMPRINT-Lung)
Single-Arm, Phase II of Immunotherapy With Pembrolizumab for the Prevention of Lung Cancer (IMPRINT-Lung)
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Other, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 2
A Phase 3, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma
A Phase 3, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma
Enrollment Status: Active_not_recruiting
Publish Date: May 20, 2025
Intervention Type: Biological, Drug
Study Drugs: rAd-IFN, Celecoxib, Gemcitabine
Study Phase: Phase 3
Bronchoscopic Cryo-Immunotherapy of Lung Cancer
Bronchoscopic Cryo-Immunotherapy of Lung Cancer
Enrollment Status: Completed
Publish Date: April 24, 2025
Intervention Type: Device
Study Phase: Early Phase 1
ZYESAMI (Aviptadil) for the Treatment of Critical COVID-19 With Respiratory Failure
ZYESAMI (Aviptadil) for the Treatment of Critical COVID-19 With Respiratory Failure
Enrollment Status: Completed
Publish Date: July 24, 2023
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
Enrollment Status: Completed
Publish Date: November 07, 2017
View 5 Less Clinical Trials

98 Total Publications

Early experience with PEF in the setting of recalcitrant stage IV lung cancer.
Early experience with PEF in the setting of recalcitrant stage IV lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 24, 2025
View All 98 Publications
Similar Doctors
Elite in Lung Cancer
Dr. Robert Downey
Intensive Care Medicine
Elite in Lung Cancer
Dr. Robert Downey
Intensive Care Medicine

Memorial Sloan Kettering Cancer Center

1275 York Ave, 
New York, NY 
 (1.8 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances

Robert Downey is an Intensive Care Medicine provider in New York, New York. Dr. Downey is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Endoscopy.

Distinguished in Lung Cancer
Dr. Robert P. Lee
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Lung Cancer
Dr. Robert P. Lee
Pulmonary Medicine | Intensive Care Medicine

Memorial Pulmonary Function Group

1275 York Ave, 
New York, NY 
 (1.8 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Lee is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in New York, New York. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Parapneumonic Pleural Effusion, Advanced Bronchoscopy, and Endoscopy. Dr. Lee is currently accepting new patients.

Advanced in Lung Cancer
Dr. Jeffrey Wolf
Intensive Care Medicine
Advanced in Lung Cancer
Dr. Jeffrey Wolf
Intensive Care Medicine

Office

233 E Shore Rd Ste 112, 
Great Neck, NY 
 (13.2 miles away)
516-798-1066
Languages Spoken:
English
See accepted insurances

Jeffrey Wolf is an Intensive Care Medicine provider in Great Neck, New York. Dr. Wolf is rated as an Advanced provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Nodules, Emphysema, Lung Cancer, Bullae, and Advanced Bronchoscopy.

VIEW MORE LUNG CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sterman's expertise for a condition
ConditionClose
    • Distinguished
    • Lung Cancer
      Dr. Sterman is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Lung Nodules
      Dr. Sterman is
      Distinguished
      . Learn about Lung Nodules.
      See more Lung Nodules experts
    • Non-Small Cell Lung Cancer (NSCLC)
      Dr. Sterman is
      Distinguished
      . Learn about Non-Small Cell Lung Cancer (NSCLC).
      See more Non-Small Cell Lung Cancer (NSCLC) experts
    • Pleural Effusion
      Dr. Sterman is
      Distinguished
      . Learn about Pleural Effusion.
      See more Pleural Effusion experts
    • Advanced
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Sterman is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • EGFR Positive Lung Cancer
      Dr. Sterman is
      Advanced
      . Learn about EGFR Positive Lung Cancer.
      See more EGFR Positive Lung Cancer experts
    • Endoscopy
      Dr. Sterman is
      Advanced
      . Learn about Endoscopy.
      See more Endoscopy experts
    • Large-Cell Lung Carcinoma
      Dr. Sterman is
      Advanced
      . Learn about Large-Cell Lung Carcinoma.
      See more Large-Cell Lung Carcinoma experts
    • Lung Adenocarcinoma
      Dr. Sterman is
      Advanced
      . Learn about Lung Adenocarcinoma.
      See more Lung Adenocarcinoma experts
    • Pneumonia
      Dr. Sterman is
      Advanced
      . Learn about Pneumonia.
      See more Pneumonia experts
    View All 8 Advanced Conditions
    • Experienced
    • Acute Interstitial Pneumonia
      Dr. Sterman is
      Experienced
      . Learn about Acute Interstitial Pneumonia.
      See more Acute Interstitial Pneumonia experts
    • Advanced Bronchoscopy
      Dr. Sterman is
      Experienced
      . Learn about Advanced Bronchoscopy.
      See more Advanced Bronchoscopy experts
    • Atypical Pneumonia
      Dr. Sterman is
      Experienced
      . Learn about Atypical Pneumonia.
      See more Atypical Pneumonia experts
    • Bronchiectasis
      Dr. Sterman is
      Experienced
      . Learn about Bronchiectasis.
      See more Bronchiectasis experts
    • Bronchogenic Cyst
      Dr. Sterman is
      Experienced
      . Learn about Bronchogenic Cyst.
      See more Bronchogenic Cyst experts
    • Bullae
      Dr. Sterman is
      Experienced
      . Learn about Bullae.
      See more Bullae experts
    View All 21 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.